Literature DB >> 4054248

Primary human marrow cultures for erythroid bursts in a serum-substituted system.

N Dainiak, S Kreczko, A Cohen, R Pannell, J Lawler.   

Abstract

To determine environmental requirements for erythroid burst formation in primary culture, we added human bone marrow cells to serum-depleted methylcellulose, agar, or fibrin clot cultures. Optimal BFU-E proliferation was present in cultures prepared with Iscove's modified Dulbecco medium, 248 micrograms/ml transferrin, 1.63 micrograms/ml ferric chloride, 117 micrograms/ml bovine serum albumin, and each of seven preparations of erythropoietin. Burst number was comparable to that in serum containing culture. Reducing sodium dodecyl sulfate electrophoresis of commercial albumin preparations showed them to contain abundant lipoproteins. Results of experiments with human plasma albumin found to be greater than 98% pure by one- and two-dimensional gel electrophoresis and delipidated albumin indicate that an albumin source is needed for burst formation to occur. Together with albumin, exogenous phosphatidylcholine but not phosphatidylserine augmented burst number. Bursts routinely appeared in serum-depleted culture without added burst-promoting activity (BPA). However, leukocyte-conditioned medium (LCM) and its high-speed supernatant and pellet fractions enhanced burst formation. Antimembrane IgG capable of neutralizing BPA reduced burst number to a level below that achieved in LCM-depleted culture, suggesting that endogenous BPA was inactivated. We conclude that human marrow BFU-E proliferation requires iron-saturated transferrin, albumin, and erythropoietin. Exogenous BPA and phospholipids enhance but are not essential for burst formation to proceed in primary culture.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054248

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Erythropoietic progenitor cells from premature neonates studied using a validated serum-deprived medium. Evidence that peripheral blood BFU-E from premature neonates are increased in number and are highly dependent upon burst promoting activity for in vitro growth.

Authors:  N B Westwood; A J Emmerson
Journal:  Cytotechnology       Date:  1991-07       Impact factor: 2.058

2.  Purification of a membrane-derived human erythroid growth factor.

Authors:  L Feldman; C M Cohen; M A Riordan; N Dainiak
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Intracellular regulation of the production and release of human erythroid-directed lymphokines.

Authors:  N Dainiak; S Sorba
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

4.  Extraction of an erythrotropin-like factor from bovine serum albumin (Cohn fraction V).

Authors:  L F Congote
Journal:  In Vitro Cell Dev Biol       Date:  1987-05

5.  Characterization of biologically active, platelet-derived growth factor-like molecules produced by murine erythroid cells in vitro and in vivo.

Authors:  A J Sytkowski; C O'Hara; G Vanasse; M J Armstrong; S Kreczko; N Dainiak
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

6.  Acetylated lipoproteins impair erythroid growth factor release from endothelial cells.

Authors:  N Dainiak; H B Warren; S Kreczko; M A Riordan; L Feldman; J Lawler; A M Cohen; P F Davies
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.